Publications by authors named "Pytlik Robert"

Claim this Profile
O
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement - real world data.
Heidi Mocikova, Andrea Janikova, Alice Sykorova, Vit Prochazka, Jan Pirnos, Robert Pytlik

Ann Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration.
Alice Sýkorová, František Folber, Kamila Polgárová, Heidi Móciková, Juraj Ďuraš, Robert Pytlík

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome.
Martin Štach, Robert Pytlík, Kristýna Šmilauerová, Jana Rychlá, Martin Mucha

Pathol Oncol Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index.
Alice Sýkorová, Vít Procházka, Heidi Móciková, Andrea Janíková, Robert Pytlík

Neoplasma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas.
Pavle Krsmanovic, Heidi Mocikova, Kamila Chramostova, Magdalena Klanova, Marie Trnkova, Robert Pytlik

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies.
Kamila Polgárová, Pavel Otáhal, Cyril Šálek, Robert Pytlík

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry.
Heidi Mocikova, Robert Pytlík, Katerina Benesova, Andrea Janikova, Juraj Duras

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells.
Tapuchova Ivana, Pytlik Robert, Simara Pavel, Tesarova Lenka, Koutna Irena

Transpl Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT.
Robert Pytlík, Blanka Vacková, Eva Konířová, Marie Trnková, Petra Blahovcová

Bone Marrow Transplant· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Various Culture Conditions on Human Mesenchymal Stromal Cells Metabolism.
Pavla Tonarova, Katerina Lochovska, Robert Pytlik, Marie Hubalek Kalbacova

Stem Cells Int· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Catenin-TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation.
Petr Danek, Miroslava Kardosova, Lucie Janeckova, Elena Karkoulia, Karolina Vanickova, Roberto Tirado-Magallanes, Robert Pytlik

Blood· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Immunotherapy Approaches in Non-Hodgkin Lymphomas.
Robert Pytlik, Kamila Polgarova, Jana Karolova, Pavel Klener

Vaccines (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL).
Andrea Janikova, Jozef Michalka, Zbynek Bortlicek, Renata Chloupkova, Vit Campr, Robert Pytlik

Ann Hematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP.
Vít Procházka, David Belada, Andrea Janíková, Kateřina Benešová, Heidi Mociková, Robert Pytlík

EJHaem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
Andrea Janikova, Renata Chloupkova, Vit Campr, Pavel Klener, Jitka Hamouzova, Robert Pytlik

Ann Hematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Jan Vydra, Veronika Válková, Barbora Čemusová, Michal Kolář, Ludmila Nováková, Robert Pytlík

Clin Lymphoma Myeloma Leuk· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry.
Aleš Obr, Vit Prochazka, Tomas Papajik, Pavel Klener, Andrea Janikova, Robert Pytlík

Leuk Lymphoma· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation.
Pavel Klener, David Salek, Robert Pytlik, Heidi Mocikova, Kristina Forsterova

Am J Hematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance.
Pavel Klener, Eva Fronkova, Marketa Kalinova, David Belada, Kristina Forsterova, Robert Pytlik

Hematol Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
Aneta Klimova, Jarmila Heissigerova, Eva Rihova, Michaela Brichova, Robert Pytlik

Br J Ophthalmol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.
Katerina Musilova, Jan Devan, Katerina Cerna, Vaclav Seda, Gabriela Pavlasova, Robert Pytlik

Blood· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group.
David Belada, Vit Prochazka, Andrea Janikova, Vit Campr, Petra Blahovcova, Robert Pytlik

Leuk Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
Andrea Janikova, Zbynek Bortlicek, Vit Campr, Natasa Kopalova, Katerina Benesova, Robert Pytlik

Ann Hematol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.
Pavel Klener, Eva Fronkova, David Belada, Kristina Forsterova, Robert Pytlik

Hematol Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry.
Heidi Mocikova, Robert Pytlik, Alice Sykorova, Andrea Janikova, Vit Prochazka

Leuk Lymphoma· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis